Exchange: NASDAQ·Updated 07:30 PM EST

About OCUL

About

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
325

Frequently Asked Questions

Advertisement|Remove ads.